COURTNEY MARES: Open Payments
NPI 1639783665 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,981 in 93 payments from 17 companies in 2025. Trend: 2023 $3,020 · 2024 $1,782 · 2025 $3,981
Food & beverage: $2,561Consulting: $1,320Education: $100
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4 | $1,449 |
| GENZYME CORPORATION | 9 | $499 |
| ABBVIE INC. | 25 | $404 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $318 |
| Organon LLC | 3 | $294 |
| Lilly USA, LLC | 9 | $189 |
| E.R. Squibb & Sons, L.L.C. | 6 | $141 |
| PFIZER INC. | 13 | $139 |
| Novartis Pharmaceuticals Corporation | 1 | $103 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $98 |
Products named: DUPIXENT, VTAMA, RINVOQ, ILUMYA, Sotyktu, SKYRIZI, TALTZ, OPZELURA.
Industry payments across NE — which companies pay providers there.
